https://websites4-live-prod.ysmdevs.com/cancer/news-rss/?orgId=115915&title=Yale+SPORE+in+Lung+Cancer+News A selection of the latest research, academic, and other newsworthy developments at SPORE in Lung Cancer en-us Copyright 2026 Yale School of Medicine Mon, 18 May 2026 00:35:36 Z https://www.cancernetwork.com/view/clinical-context-mariposa-efficacy-in-1l-egfrm-nsclc https://www.cancernetwork.com/view/clinical-context-mariposa-efficacy-in-1l-egfrm-nsclc Dr. Sarah Goldberg from Yale University School of Medicine and Dr. Misako Nagasaka from UCI Health open a discussion on subcutaneous amivantamab every 4 weeks plus lazertinib as a first-line treatment for EGFR-mutated advanced non–small cell lung cancer (NSCLC). Tue, 12 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ Yale Cancer Center faculty and trainees joined over 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in San Diego for the 117th American Association for Cancer Research (AACR) annual meeting. Thu, 23 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/david-rimm-md-phd-chosen-for-pathology-cancer-research-award/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/david-rimm-md-phd-chosen-for-pathology-cancer-research-award/ The American Association for Cancer Researcher (AACR) named David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and of Medicine (Medical Oncology), as recipient of the 2026 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research. Fri, 10 Apr 2026 14:15:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/lung-cancer-development-treatment-and-what-comes-next/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/lung-cancer-development-treatment-and-what-comes-next/ Why do some lung cancers stop responding to drugs that once worked? And why does the immune system sometimes fail to recognize and destroy tumors? Pathologist Katerina Politi, PhD, has spent more than two decades pursuing those questions, and her team at Yale School of Medicine is now closer to finding answers that could reshape how patients are treated. Wed, 08 Apr 2026 18:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/center-for-thoracic-cancers-hosts-celebrate-the-unexpected/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/center-for-thoracic-cancers-hosts-celebrate-the-unexpected/ On Tuesday, April 7, 2026, the Center for Thoracic Cancers hosted a special event for patients and caregivers, with Annabelle Gurwitch. Wed, 08 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-hosts-the-paul-calabresi-md-memorial-lecture/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-hosts-the-paul-calabresi-md-memorial-lecture/ On Tuesday, March 31, 2026, Dr. Robert A. Winn, Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center, and Professor of Pulmonary Disease and Critical Care Medicine at VCU School of Medicine presented the Paul Calabresi, MD, Memorial Lectureship, hosted by Roy Herbst, MD, PhD. A dinner was held in his honor, along with a ceremony in the Calabresi Conference Room at Yale Cancer Center. Yale Medical Oncology-Hematology Fellows also had a chance to speak with Dr. Winn following his talk. Wed, 01 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/ai-in-cancer-workshop-advancing-precision-medicine-through-interdisciplinary-innovation/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/ai-in-cancer-workshop-advancing-precision-medicine-through-interdisciplinary-innovation/ On Friday, March 20th, the Precision Medicine in Cancer Program at Yale Cancer Center hosted a day long workshop focused on real-world applications of AI across the cancer care continuum, from bench to clinical implementation to population health. Tue, 24 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/connecticut-academy-of-science-and-engineering-elects-eight-from-ysm/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/connecticut-academy-of-science-and-engineering-elects-eight-from-ysm/ Eight Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering. Fri, 13 Mar 2026 14:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-ai-tool-helps-scientists-see-how-cells-work-together-inside-diseased-tissue/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-ai-tool-helps-scientists-see-how-cells-work-together-inside-diseased-tissue/ A new study from Yale University researchers shows how artificial intelligence can bring different kinds of data together, offering a clearer picture of what is happening inside the body and how diseases develop. Tue, 10 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-centers-crtec-hosts-cancer-research-discovery-program/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-centers-crtec-hosts-cancer-research-discovery-program/ On February 6, 2026, YCC CRTEC welcomed students from Hill Regional Career High School to our Cancer Research Discovery Program (CRDP), a day designed to introduce them to careers in cancer research and medicine. Tue, 10 Feb 2026 05:00:00 Z https://www.statnews.com/2026/02/02/cancer-immunotherapy-morning-infusions-most-effective-study-says/ https://www.statnews.com/2026/02/02/cancer-immunotherapy-morning-infusions-most-effective-study-says/ While the study is a signal that time of day for immunotherapy infusion is worth investigating further, Roy Herbst, the deputy director of the Yale Cancer Center, said he’s not going to change practice based on the trial. “It’s intriguing. This is maybe a wake-up call to look at it more," Herbst said. Mon, 02 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/standout-research-clinical-care-and-staff-support-recognized/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/standout-research-clinical-care-and-staff-support-recognized/ A dozen awards honored 15 people at January's Yale Cancer Center Annual Awards for work in 2025. Wed, 28 Jan 2026 05:00:00 Z https://time.com/7358444/lung-cancer-screening-ct/ https://time.com/7358444/lung-cancer-screening-ct/ Medical oncologist Dr. Roy S. Herbst explains the importance of cancer screenings Wed, 28 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/genetic-study-of-rare-endometrial-cancer-uncovers-potential-treatments/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/genetic-study-of-rare-endometrial-cancer-uncovers-potential-treatments/ Researchers uncovered potential treatment strategies for stromal sarcoma of the uterus by establishing a more detailed understanding of the aggressive tumors at the molecular level. Mon, 26 Jan 2026 20:00:00 Z https://www.nytimes.com/2026/01/22/health/lung-cancer-antibodies-immune-system.html https://www.nytimes.com/2026/01/22/health/lung-cancer-antibodies-immune-system.html Nytimes article about antibodies that can defeat cancer -- could they become a treatment? Fri, 23 Jan 2026 05:00:00 Z https://www.nejm.org/doi/full/10.1056/NEJMe2514042 https://www.nejm.org/doi/full/10.1056/NEJMe2514042 Combination chemotherapy has long been a mainstay of cancer treatment, although early mechanism-based therapies showed little promise. More than 50 years later, this foundational principle — in which biologic rationale is used to guide the choice of treatment combinations — is being applied to the leading cause of cancer-related deaths: lung cancer. Today, genomic profiling, targeted agents, and strategies informed by resistance mechanisms are reshaping care for epithelial growth factor receptor (EGFR)–mutated non–small-cell lung cancer (NSCLC). Mon, 05 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/clinical-trials-target-brain-metastases/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/clinical-trials-target-brain-metastases/ Veronica Chiang, MD, professor of neurosurgery, is currently leading several clinical trials seeking to improve treatments for brain metastases, or cancers that has spread to the brain). She recently sat down for an interview about this important work. Mon, 22 Dec 2025 05:00:00 Z https://transcripts.cnn.com/show/cg/date/2025-12-22/segment/02 https://transcripts.cnn.com/show/cg/date/2025-12-22/segment/02 Legendary singer songwriter Barry Manilow reveals that he's been diagnosed with lung cancer. We'll ask a lung cancer specialist what sort of treatment may lie ahead. Mon, 22 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-research-in-breast-cancer-and-hematology-showcased-at-national-meetings/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-research-in-breast-cancer-and-hematology-showcased-at-national-meetings/ Members of the Center for Breast Cancer and the Hematology Program at Yale Cancer Center and Smilow Cancer Hospital recently presented their latest groundbreaking research on two national stages. First at the annual American Society of Hematology (ASH) meeting, followed by the annual San Antonio Breast Cancer Symposium (SABCS). Tue, 16 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-research-advances-presented-at-san-antonio-breast-cancer-symposium-annual-meeting/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-research-advances-presented-at-san-antonio-breast-cancer-symposium-annual-meeting/ Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center attended the 48th annual San Antonio Breast Cancer Symposium (SABCS), from December 9-12, 2025. Sat, 13 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-research-advances-presented-at-american-society-of-hematology-annual-meeting2025/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-research-advances-presented-at-american-society-of-hematology-annual-meeting2025/ Physicians, scientists, and trainees from Yale Cancer Center and Smilow Cancer Hospital attended the 67th annual meeting of the American Society of Hematology in Orlando, FL, December 6-9, 2025 to present the latest advances in hematological research and clinical care from Yale. Tue, 09 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-to-present-breakthrough-breast-cancer-research-at-international-conference-in-texas/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-to-present-breakthrough-breast-cancer-research-at-international-conference-in-texas/ At SABCS, Yale Cancer Center experts will present groundbreaking research on hormone replacement therapy in breast cancer care, innovative treatment options for HER2-positive and hormone receptor-positive breast cancers, and the impact of patient-centered approaches to care. Mon, 01 Dec 2025 12:00:00 Z https://medicine.yale.edu/ysm/news/yale-medicine-magazine/article/the-fundamentals-and-future-of-cancer-treatment/ https://medicine.yale.edu/ysm/news/yale-medicine-magazine/article/the-fundamentals-and-future-of-cancer-treatment/ In a Q&A, Lieping Chen, MD, PhD, discusses his research, immunotherapy, and the future of cancer treatment. Mon, 01 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/progress-and-hope-sharing-the-latest-advances-in-lung-cancer-care/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/progress-and-hope-sharing-the-latest-advances-in-lung-cancer-care/ On November 17, 2025, in honor of Lung Cancer Awareness Month, members of our Center for Thoracic Cancers at Smilow Cancer Hospital and Yale Cancer Center presented a patient forum: "Progress and Hope: Sharing the Latest Advances in Lung Cancer Care." The event was held in person at 55 Park Street in New Haven, CT. Tue, 18 Nov 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/the-power-of-progress-in-lung-cancer/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/the-power-of-progress-in-lung-cancer/ Dr. Roy Herbst shares the progress that has been made in lung cancer care and research at Smilow Cancer Hospital and Yale Cancer Center. Thu, 13 Nov 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/twenty-seven-ysm-faculty-members-recognized-for-highly-cited-research/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/twenty-seven-ysm-faculty-members-recognized-for-highly-cited-research/ Yale School of Medicine faculty members were recognized for publishing studies that rank in the top 1% based on the number of citations they received in their field. Wed, 12 Nov 2025 08:00:00 Z https://www.nbcconnecticut.com/video/news/local/report-shows-that-doctors-are-finding-lung-cancer-cases-earlier/3661653/ https://www.nbcconnecticut.com/video/news/local/report-shows-that-doctors-are-finding-lung-cancer-cases-earlier/3661653/ A new report from the American Lung Association is giving some helpful news about lung cancer. Dr. Roy Herbst, deputy director and chief of medical oncology and hematology for Yale Cancer Center and Smilow Cancer Hospital, spoke with NBC Connecticut about the advances in lung cancer detection, treatment, and research. Fri, 07 Nov 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/advancing-biomedical-innovation-yale-boehringer-ingelheim-fellowship-colloquium-and-strategy-meeting/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/advancing-biomedical-innovation-yale-boehringer-ingelheim-fellowship-colloquium-and-strategy-meeting/ On Thursday, September 19, 2025, Yale University welcomed colleagues from academia and industry for the annual Yale–Boehringer Ingelheim Biomedical Data Science Fellowship (BMDS) Colloquium and Joint Steering Committee meeting. Hosted in New Haven, the gathering brought together faculty, postdoctoral fellows, and leaders from Yale and Boehringer Ingelheim (BI) to celebrate progress, showcase research, and chart the fellowship’s future. Fri, 31 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/ycc-publlications-2025/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/ycc-publlications-2025/ Publications regarding cancer attributed to first- and last-authors of published papers Mon, 27 Oct 2025 16:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/brueckner-chen-horvath-elected-to-national-academy-of-medicine/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/brueckner-chen-horvath-elected-to-national-academy-of-medicine/ Martina Brueckner, MD, Lieping Chen, MD, PhD, and Tamas Horvath, DVM, PhD, have been elected to the National Academy of Medicine. Mon, 20 Oct 2025 13:30:00 Z https://www.statnews.com/sponsor/2020/08/27/new-fda-approved-adjuvant-treatment-option-for-resectable-non-small-cell-lung-cancer/ https://www.statnews.com/sponsor/2020/08/27/new-fda-approved-adjuvant-treatment-option-for-resectable-non-small-cell-lung-cancer/ “There remains a high rate of recurrence in patients with resectable NSCLC, even after tumor resection,” said Roy Herbst, MD, PhD, the principal investigator of the ADAURA trial and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital. “With the approval of TAGRISSO in the adjuvant setting (after surgery), we now have an EGFR TKI that has shown a disease-free survival benefit, which has the potential to change how we treat patients with resectable EGFRm NSCLC.” Wed, 15 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/google-maps-approach-to-revolutionize-lung-cancer-treatment/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/google-maps-approach-to-revolutionize-lung-cancer-treatment/ Researchers, led by Thazin Nwe Aung, PhD, in the laboratory of David Rimm, MD, PhD, have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective individualized treatment. Fri, 10 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/multi-day-cancer-symposium-lays-groundwork-for-research-collaboration/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/multi-day-cancer-symposium-lays-groundwork-for-research-collaboration/ An intensive two-day Yale Cancer Research symposium, dedicated to advancing cancer science through innovation and strengthening partnerships between Yale University and Historically Black Colleges and Universities (HBCUs), brought together researchers from multiple disciplines this week. Tue, 07 Oct 2025 04:00:00 Z https://www.cancernetwork.com/view/exploring-the-next-frontier-of-cancer-biomarkers-in-precision-medicine https://www.cancernetwork.com/view/exploring-the-next-frontier-of-cancer-biomarkers-in-precision-medicine Regarding finding the right drug for the right patient, the reality of cancer management is far more complex than a single genetic mutation, according to David Rimm, MD, PhD. Fri, 03 Oct 2025 04:00:00 Z https://lungcancer.einnews.com/article_detail/854993640/N1ab33qE2mnve8OL?ref=rss&lcode=6subgp9aevZe_rc9PA4Sow%3D%3D https://lungcancer.einnews.com/article_detail/854993640/N1ab33qE2mnve8OL?ref=rss&lcode=6subgp9aevZe_rc9PA4Sow%3D%3D The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for certain adults with extensive-stage small cell lung cancer.This indication of lurbinectedin (Zepzelca; Jazz Pharmaceuticals, Pharma Mar) applies to adults whose disease has not progressed after first-line induction therapy with atezolizumab (Tecentriq, Genentech), carboplatin and etoposide. Fri, 03 Oct 2025 04:00:00 Z https://www.cancernetwork.com/view/looking-beyond-genomics-to-advance-precision-medicine-in-cancer-care https://www.cancernetwork.com/view/looking-beyond-genomics-to-advance-precision-medicine-in-cancer-care It may be time for precision medicine to expand beyond the genomics realm and enter the protein space in the management of melanoma and other cancers, according to David Rimm, MD, PhD. Fri, 03 Oct 2025 04:00:00 Z https://www.cancernetwork.com/view/advancing-ai-in-pathology-precision-medicine-and-the-melanoma-landscape https://www.cancernetwork.com/view/advancing-ai-in-pathology-precision-medicine-and-the-melanoma-landscape Dr. David Rimm spoke with Cancer Network on his latest research. Wed, 01 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/dr-sarah-goldberg-receives-2025-lcrf-or-bayer-lung-cancer-research-award/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/dr-sarah-goldberg-receives-2025-lcrf-or-bayer-lung-cancer-research-award/ Sarah Goldberg, MD, MPH, has received one of two lung cancer research awards from the Lung Cancer Research Foundation, in collaboration with Bayer Pharmaceuticals. Tue, 30 Sep 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yales-review-of-advances-in-oncology-highlights-from-the-asco-annual-meeting-2025/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yales-review-of-advances-in-oncology-highlights-from-the-asco-annual-meeting-2025/ On Friday, September 26, 2025, Yale's Review of Advances in Oncology from the 2025 ASCO Annual Meeting was held at the New Haven Lawn Club. The keynote speaker for the event was Veronica Chiang, MD, FAANS, professor of neurosurgery, director of Stereotactic Radiosurgery, and director of the Yale Gamma Knife Center. Mon, 29 Sep 2025 04:00:00 Z https://lungcancer.einnews.com/article_detail/851793733/aRNYHsMdHXpIE6ZW?ref=rss&lcode=6subgp9aevZe_rc9PA4Sow%3D%3D https://lungcancer.einnews.com/article_detail/851793733/aRNYHsMdHXpIE6ZW?ref=rss&lcode=6subgp9aevZe_rc9PA4Sow%3D%3D Dr. Roy S. Herbst discusses advancements in EGFR-targeted therapies for early-stage NSCLC, highlighting improved survival rates and the role of molecular residual disease. Tue, 23 Sep 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-experts-to-present-new-research-at-worlds-top-radiation-oncology-conference/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-experts-to-present-new-research-at-worlds-top-radiation-oncology-conference/ AT ASTRO 2025, Yale Cancer Center experts will present research across key areas, including novel radiation therapy techniques, personalized treatment strategies, and innovations in managing breast, prostate, and lung cancers. Thu, 18 Sep 2025 04:00:00 Z https://www.oncologynewscentral.com/nsclc/long-term-data-show-lasting-survival-benefit-with-cemiplimab-in-advanced-nsclc https://www.oncologynewscentral.com/nsclc/long-term-data-show-lasting-survival-benefit-with-cemiplimab-in-advanced-nsclc Roy S. Herbst, MD, PhD, from Yale Cancer Center in New Haven, Connecticut, called the five-year results “extraordinary,” noting that cemiplimab performed on par with pembrolizumab (Keytruda) and other leading PD-1 inhibitors in the PD-L1–high population. He added that these data reinforce the strength of PD-1 blockade in frontline NSCLC, where long-term survival now approaches cure for a subset of patients. “It shows that cemiplimab is as good as the very best PD-1 inhibitors out there,” Dr. Herbst said. Tue, 16 Sep 2025 04:00:00 Z https://www.statnews.com/2025/09/09/health-news-lung-cancer-florida-trump-fda-pig-kidney/ https://www.statnews.com/2025/09/09/health-news-lung-cancer-florida-trump-fda-pig-kidney/ BioNTech presented at the World Conference on Lung Cancer some promising Phase 2 data on a novel immunotherapy that targets two key proteins, PDL1 and VEGF. During the trial, the tumors of all 43 patients either shrank or did not progress, and 76.3% of patients saw significant tumor reduction. The average amount that tumors shrank was 56.7% in the trial. “These are impressive but small numbers,” said Roy Herbst, deputy director of the Yale Cancer Center, who did not work on the study, adding that it will be key to see whether the benefits persist. “But good forward progress so far.” Tue, 09 Sep 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/shuta-ishibe-appointed-chief-of-nephrology/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/shuta-ishibe-appointed-chief-of-nephrology/ Shuta Ishibe, MD, has been appointed the new chief of the Section of Nephrology in the Department of Internal Medicine at Yale School of Medicine. Tue, 09 Sep 2025 04:00:00 Z https://www.wtnh.com/news/health/yale-cancer-center-researchers-using-ai-in-melanoma-research/ https://www.wtnh.com/news/health/yale-cancer-center-researchers-using-ai-in-melanoma-research/ David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and professor of medicine at Yale School of Medicine, discussed two important developments to come out of his lab. Mon, 25 Aug 2025 14:05:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/study-reveals-insights-into-therapeutic-vulnerabilities-for-rare-aggressive-lung-cancer/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/study-reveals-insights-into-therapeutic-vulnerabilities-for-rare-aggressive-lung-cancer/ A multi-institution study of nearly 600 patients with a rare and aggressive form of lung cancer offers new insights into the comparative effects of existing therapies and potential targets for future treatments. It was published Aug. 19, 2025 in Nature Communications. First author Amin Nassar, MD, Yale hematology/oncology fellow, senior author Anne Chiang, MD, PhD, Yale Lung SPORE et al Thu, 21 Aug 2025 14:00:00 Z https://www.nbcconnecticut.com/video/news/local/could-ai-soon-help-people-with-cancer/3627558/ https://www.nbcconnecticut.com/video/news/local/could-ai-soon-help-people-with-cancer/3627558/ Yale Cancer Center researchers are trying to figure out if artificial intelligence can help people with cancer. They found that AI-based scoring of melanoma tumor-infiltrating immune cells, significantly outperforms traditional pathologist eyeballing. Wed, 20 Aug 2025 04:00:00 Z https://www.healio.com/news/hematology-oncology/20250804/assay-has-huge-potential-directing-antibodydrug-conjugate-treatment-for-breast-cancer https://www.healio.com/news/hematology-oncology/20250804/assay-has-huge-potential-directing-antibodydrug-conjugate-treatment-for-breast-cancer Yale Cancer Center researcher David Rimm, MD, PhD, who is the Anthony N. Brady Professor of Pathology, and colleagues developed a novel assay to measure HER2 and TROP2 levels in patients with breast cancer. These data could help physicians decide which antibody-drug conjugates should be used in each individual case. Mon, 04 Aug 2025 04:00:00 Z https://www.wtnh.com/news/health/august-1-is-world-lung-cancer-day/ https://www.wtnh.com/news/health/august-1-is-world-lung-cancer-day/ It's World Lung Cancer Day. It’s observed every year to raise awareness about the disease and encourage early detection. Dr. Roy Herbst, a lung cancer physician and deputy director of Yale Cancer Center and chief of medical oncology and hematology at Smilow Cancer Hospital and Yale Cancer Center, joined Good Morning Connecticut at 9 a.m. to discuss. Fri, 01 Aug 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/digging-into-data-science-at-the-38th-annual-new-england-statistical-symposium/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/digging-into-data-science-at-the-38th-annual-new-england-statistical-symposium/ The 38th annual New England Statistical Symposium (NESS) drew more than 300 graduate students, academic experts, and industry leaders to New Haven for workshops and discussions on the latest advances and research trends. Wed, 23 Jul 2025 04:00:00 Z